BioVie News

Latest BioVie Stock News & BIVI Headlines

BioVie Invited to Present Data on Bezisterim in Parkinson's Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson's Diseases

5 days ago | globenewswire.com

BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop

6 days ago | globenewswire.com

BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

11 days ago | globenewswire.com

BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026

13 days ago | globenewswire.com

BioVie Inc. (NASDAQ:BIVI) Shares Shorted: Short Interest Down 34.5% in October

13 days ago | defenseworld.net

BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH's RECOVER-TLC Third Annual Workshop

20 days ago | globenewswire.com

BioVie reports positive Phase 2 Parkinson's data for bezisterim

a month ago | proactiveinvestors.com

BioVie Presents Data on Bezisterim in Parkinson's Disease at the 2026 American Neurological Association Annual Meeting

a month ago | globenewswire.com

BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroups

a month ago | proactiveinvestors.com

BioVie to present Long COVID and Parkinson's trial results at American Neurological Association meeting

a month ago | proactiveinvestors.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

BIVI

BioVie

$ 1.13

-5.04%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

BioVie News

Latest BioVie Stock News & BIVI Headlines

Download App

People Also Watch

Explore our Tools